← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:1188 | 1188 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-013 | 73198-013-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1188 | 1188 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1188 | 1188 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9010 | 71266-9010-2 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1188 | 1188 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-08 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1188 | 1188 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-026 | 70713-026-01 | Progesterone | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1188 | 1188 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-070 | 71449-070-25 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1188 | 1188 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Semaglutide | 2026-1 | source_no_ndc | 1 | 2026-10-20 | |||
compounder:1189 | 1189 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1818 | 72907-1818-5 | Triamcinolone Acetonide | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1189 | 1189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0428 | 72196-0428-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2019-1 | valid | 0 | 2026-10-20 | |
outsourcing:2019-2:1189 | 1189 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1189 | 1189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-922 | 69374-922-03 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1189 | 1189 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-1:1189 | 1189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-6 | Morphine Sulfate | 2021-1 | valid | 0 | 2026-10-20 | |
outsourcing:2021-2:1189 | 1189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-01 | Morphine Sulfate | 2021-2 | valid | 0 | 2026-10-20 | |
outsourcing:2022-1:1189 | 1189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-956 | 69374-956-10 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-20 | |
outsourcing:2022-2:1189 | 1189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6008 | 71286-6008-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1189 | 1189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-010 | 73198-010-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1189 | 1189 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1189 | 1189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9032 | 71266-9032-1 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1189 | 1189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-05 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1189 | 1189 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Proline | 2025-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2025-2:1189 | 1189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-588 | 70092-588-38 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1189 | 1189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-495 | 71170-495-05 | Semaglutide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1190 | 1190 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9034 | 83826-9034-5 | Moxifloxacin, Bromfenac | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1190 | 1190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0400 | 71285-0400-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Valine; Phenylalanine; Tryptophan | 2019-1 | valid | 0 | 2026-10-20 | |
outsourcing:2019-2:1190 | 1190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0894 | 5446-0894-01 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-20 | |
outsourcing:2020-1:1190 | 1190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-942 | 69374-942-04 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1190 | 1190 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-1:1190 | 1190 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1190 | 1190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-04 | Morphine Sulfate | 2021-2 | valid | 0 | 2026-10-20 | |
outsourcing:2022-1:1190 | 1190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-955 | 69374-955-10 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-20 | |
outsourcing:2022-2:1190 | 1190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1418 | 61141-1418-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1190 | 1190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-010 | 73198-010-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1190 | 1190 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1190 | 1190 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-2:1190 | 1190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6028 | 26436-6028-3 | Procaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1190 | 1190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0404 | 72196-0404-1 | Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1190 | 1190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-333 | 70092-333-75 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1190 | 1190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-821 | 71170-821-01 | Semaglutide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1191 | 1191 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-014 | 73198-014-05 | T-101 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1191 | 1191 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutamine | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1191 | 1191 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-750 | 70004-750-09 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-20 | |
outsourcing:2020-1:1191 | 1191 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-932 | 69374-932-03 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1191 | 1191 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-1:1191 | 1191 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1191 | 1191 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1191 | 1191 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1191 | 1191 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-493 | 76154-493-15 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1191 | 1191 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-025 | 73198-025-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1191 | 1191 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1191 | 1191 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1191 | 1191 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 67157-005 | 67157-005-30 | Procaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1191 | 1191 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Proline; Lysine Hydrochloride; Arginine Hydrochloride; Citrulline | 2025-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2025-2:1191 | 1191 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-657 | 70092-657-76 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1191 | 1191 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-811 | 71170-811-02 | Semaglutide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1192 | 1192 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-004 | 72055-004-01 | Oxytocin | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1192 | 1192 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1192 | 1192 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-750 | 70004-750-25 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-20 | |
outsourcing:2020-1:1192 | 1192 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-902 | 69374-902-05 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1192 | 1192 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-528 | 69374-528-28 | Norepinephrine | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1192 | 1192 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6795 | 60652-6795-2 | Morphine Sulfate | 2021-1 | valid | 0 | 2026-10-20 | |
outsourcing:2021-2:1192 | 1192 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1192 | 1192 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1192 | 1192 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-494 | 76154-494-15 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1192 | 1192 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-023 | 73198-023-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1192 | 1192 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1192 | 1192 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5250 | 71266-5250-1 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1192 | 1192 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-026 | 70713-026-01 | Progesterone | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1192 | 1192 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4536 | 61141-4536-4 | Proparacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1192 | 1192 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-335 | 70092-335-76 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1192 | 1192 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5635 | 26436-5635-5 | Semaglutide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1193 | 1193 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-113 | 73198-113-10 | Diluent for Reconstitution | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1193 | 1193 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1193 | 1193 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0749 | 5446-0749-10 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-20 | |
outsourcing:2020-1:1193 | 1193 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3324 | 62295-3324-5 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1193 | 1193 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-528 | 69374-528-25 | Norepinephrine | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1193 | 1193 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1193 | 1193 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1193 | 1193 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7025 | 71285-7025-1 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-20 | |
outsourcing:2022-2:1193 | 1193 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-852 | 76154-852-15 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1193 | 1193 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-023 | 73198-023-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1193 | 1193 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1193 | 1193 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5130 | 71266-5130-1 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1193 | 1193 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5617 | 26436-5617-1 | Progesterone | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1193 | 1193 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Proparacaine Hydrochloride; Povidone-Iodine | 2025-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2025-2:1193 | 1193 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-59 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1193 | 1193 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5608 | 26436-5608-2 | Semaglutide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1194 | 1194 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-170 | 70092-170-05 | Phenylephrine 40 mg add to 250ml NS bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1194 | 1194 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1194 | 1194 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9020 | 71266-9020-5 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-20 | |
outsourcing:2020-1:1194 | 1194 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2020-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-2:1194 | 1194 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-533 | 69374-533-28 | Norepinephrine | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1194 | 1194 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-50 | Morphine Sulfate | 2021-1 | valid | 0 | 2026-10-20 | |
outsourcing:2021-2:1194 | 1194 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1194 | 1194 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-053 | 71506-053-58 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-20 | |
outsourcing:2022-2:1194 | 1194 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-853 | 76154-853-15 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1194 | 1194 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-023 | 73198-023-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1194 | 1194 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1194 | 1194 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5170 | 71266-5170-1 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1194 | 1194 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5380 | 26436-5380-1 | Progesterone | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1194 | 1194 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2424 | 72627-2424-1 | Pyridoxine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1194 | 1194 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-57 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1194 | 1194 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-173 | 73198-173-10 | Sermorelin Acetate | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1195 | 1195 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5080 | 26436-5080-3 | Lysine 100mg/mL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1195 | 1195 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1195 | 1195 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3324 | 62295-3324-5 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-20 | |
outsourcing:2020-1:1195 | 1195 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2020-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-2:1195 | 1195 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-533 | 69374-533-25 | Norepinephrine | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1195 | 1195 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-02 | Morphine Sulfate | 2021-1 | valid | 0 | 2026-10-20 | |
outsourcing:2021-2:1195 | 1195 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1195 | 1195 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-040 | 71506-040-10 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-20 | |
outsourcing:2022-2:1195 | 1195 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-854 | 76154-854-15 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1195 | 1195 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-024 | 73198-024-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1195 | 1195 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1195 | 1195 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8211 | 71266-8211-1 | Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride; Tropicamide | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1195 | 1195 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-036 | 70713-036-01 | Progesterone | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1195 | 1195 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Pyridoxine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2025-2:1195 | 1195 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-51 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1195 | 1195 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5647 | 26436-5647-2 | Sermorelin Acetate | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1196 | 1196 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1818 | 72907-1818-3 | Triamcinolone Acetonide | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2019-1 | valid | 0 | 2026-10-20 | |
outsourcing:2019-2:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-20 | |
outsourcing:2020-1:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6065 | 72196-6065-1 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1196 | 1196 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-1:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-30 | Morphine Sulfate | 2021-1 | valid | 0 | 2026-10-20 | |
outsourcing:2021-2:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1050 | 5446-1050-01 | Moxifloxacin | 2021-2 | valid | 0 | 2026-10-20 | |
outsourcing:2022-1:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-026 | 71506-026-51 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-20 | |
outsourcing:2022-2:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-855 | 76154-855-15 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-024 | 73198-024-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1196 | 1196 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8211 | 71266-8211-5 | Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride; Tropicamide | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5248 | 26436-5248-1 | Progesterone | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6858 | 72682-6858-1 | Pyridoxine Hydrochloride; Magnesium Chloride; Dexpanthenol; Calcium Gluconate; Thiamine Hydrochloride; Niacinamide; Cyanocobalamin; Riboflavin | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1196 | 1196 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9130 | 71266-9130-1 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1196 | 1196 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2026-1 | source_no_ndc | 1 | 2026-10-20 | |||
compounder:1197 | 1197 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6646 | 71300-6646-3 | Naltrexone HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1197 | 1197 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2402 | 72627-2402-1 | Glutathione | 2019-1 | valid | 0 | 2026-10-20 | |
outsourcing:2019-2:1197 | 1197 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-20 | |
outsourcing:2020-1:1197 | 1197 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9020 | 71266-9020-5 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1197 | 1197 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-1:1197 | 1197 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1050 | 5446-1050-01 | Moxifloxacin | 2021-1 | valid | 0 | 2026-10-20 | |
outsourcing:2021-2:1197 | 1197 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1197 | 1197 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-008 | 71506-008-58 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-20 | |
outsourcing:2022-2:1197 | 1197 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2023-1:1197 | 1197 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-016 | 73198-016-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1197 | 1197 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1197 | 1197 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride; Tropicamide | 2024-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-2:1197 | 1197 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-3020 | 70168-3020-1 | Progesterone | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1197 | 1197 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Pyridoxine Hydrochloride; Niacinamide; Riboflavin 5'-Phosphate; Dexpanthenol; Thiamine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2025-2:1197 | 1197 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-128 | 73702-128-65 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1197 | 1197 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2026-1 | source_no_ndc | 1 | 2026-10-20 | |||
compounder:1198 | 1198 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9115 | 71266-9115-1 | Hydromorphone HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1198 | 1198 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1198 | 1198 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1198 | 1198 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1198 | 1198 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-504 | 69374-504-28 | Norepinephrine | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1198 | 1198 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-846 | 33216-846-04 | Moxifloxacin | 2021-1 | valid | 0 | 2026-10-20 | |
outsourcing:2021-2:1198 | 1198 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 2021-2 | valid | 0 | 2026-10-20 | |
outsourcing:2022-1:1198 | 1198 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-20 | |
outsourcing:2022-2:1198 | 1198 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2023-1:1198 | 1198 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-016 | 73198-016-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1198 | 1198 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1198 | 1198 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8241 | 71266-8241-5 | Phenylephrine Hydrochloride; Ketorolac Tromethamine; Tropicamide; Cyclopentolate Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1198 | 1198 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5152 | 26436-5152-1 | Progesterone | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1198 | 1198 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-0010 | 72682-0010-1 | Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1198 | 1198 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-211 | 73702-211-02 | Ropivacaine Hydrochloride; Fentanyl | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1198 | 1198 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2026-1 | source_no_ndc | 1 | 2026-10-20 | |||
compounder:1199 | 1199 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0428 | 72196-0428-1 | Trophamine 3% / Dextrose 10% With Calcium Gluconate 2.33mEq and Heparin 125 units 250ml in 250ml bag | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1199 | 1199 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1199 | 1199 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1199 | 1199 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1199 | 1199 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-504 | 69374-504-25 | Norepinephrine | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1199 | 1199 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1199 | 1199 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 2021-2 | valid | 0 | 2026-10-20 | |
outsourcing:2022-1:1199 | 1199 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-170 | 70092-170-05 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-20 | |
outsourcing:2022-2:1199 | 1199 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-301 | 69374-301-10 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1199 | 1199 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-012 | 73198-012-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1199 | 1199 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1199 | 1199 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8241 | 71266-8241-1 | Phenylephrine Hydrochloride; Ketorolac Tromethamine; Tropicamide; Cyclopentolate Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1199 | 1199 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-3030 | 70168-3030-1 | Progesterone | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1199 | 1199 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Riboflavin 5'-Phosphate Sodium; Ascorbic Acid; Magnesium Chloride; Dexpanthenol; Niacinamide; Calcium Gluconate; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2025-2:1199 | 1199 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-5340 | 71139-5340-2 | Ropivacaine Hydrochloride; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1199 | 1199 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sermorelin Acetate | 2026-1 | source_no_ndc | 1 | 2026-10-20 | |||
compounder:1200 | 1200 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0070 | 70168-0070-1 | Testo80mg | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1200 | 1200 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1200 | 1200 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1200 | 1200 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2020-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-2:1200 | 1200 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-1:1200 | 1200 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1200 | 1200 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1200 | 1200 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-044 | 70092-044-05 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-20 | |
outsourcing:2022-2:1200 | 1200 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-302 | 69374-302-10 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1200 | 1200 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-012 | 73198-012-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1200 | 1200 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1200 | 1200 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8240 | 71266-8240-1 | Phenylephrine Hydrochloride; Ketorolac Tromethamine; Tropicamide; Cyclopentolate Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1200 | 1200 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Proline | 2024-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2025-1:1200 | 1200 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5471 | 26436-5471-3 | Riboflavin 5'-Phosphate Sodium; Niacinamide; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1200 | 1200 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-5340 | 71139-5340-4 | Ropivacaine Hydrochloride; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1200 | 1200 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5424 | 26436-5424-2 | Sermorelin Acetate | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1201 | 1201 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-435 | 70092-435-46 | Acetaminophen 10 mg/ml 10 ml syr PF | 2026-1 | valid | 0 | 2026-09-18 |